➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Baxter
McKesson
Express Scripts
Dow

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Ubrogepant - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for ubrogepant and what is the scope of patent protection?

Ubrogepant is the generic ingredient in one branded drug marketed by Allergan and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Ubrogepant has eighty-five patent family members in forty countries.

One supplier is listed for this compound.

Summary for ubrogepant
International Patents:85
US Patents:5
Tradenames:1
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Bulk Api Vendors: 12
Clinical Trials: 5
Patent Applications: 19
DailyMed Link:ubrogepant at DailyMed
Recent Clinical Trials for ubrogepant

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
AllerganPhase 1
AllerganPhase 3

See all ubrogepant clinical trials

US Patents and Regulatory Information for ubrogepant

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan UBRELVY ubrogepant TABLET;ORAL 211765-001 Dec 23, 2019 RX Yes No   Start Trial   Start Trial Y Y   Start Trial
Allergan UBRELVY ubrogepant TABLET;ORAL 211765-001 Dec 23, 2019 RX Yes No   Start Trial   Start Trial Y   Start Trial
Allergan UBRELVY ubrogepant TABLET;ORAL 211765-002 Dec 23, 2019 RX Yes Yes   Start Trial   Start Trial   Start Trial
Allergan UBRELVY ubrogepant TABLET;ORAL 211765-002 Dec 23, 2019 RX Yes Yes   Start Trial   Start Trial Y Y   Start Trial
Allergan UBRELVY ubrogepant TABLET;ORAL 211765-001 Dec 23, 2019 RX Yes No   Start Trial   Start Trial Y Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
McKesson
Johnson and Johnson
Colorcon
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.